Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis. Benkert TF, Dietz L, Hartmann EM, Leich E, Rosenwald A, Serfling E, Buttmann M, Berberich-Siebelt F PLoS One. 2012; 7(12):e52208. Epub 2012 Dec 20. PMID: 23284936. Abstract CommentRecommendBookmarkWatch